IFNA2 and pneumococcal infection: However, IFNα subtypes likely provide beneficial effects as well since a separate study showed that prophylactic or therapeutic administration (i.n.)of an adenoviral vector expressing IFNα enhanced survival after pneumococcal infection and decreased lung and spleen bacterial burden (149).